Evidence map›Paper›PMID 36523815›Full record

ArticleFrontiers in cellular neuroscience2022

Visualization of real-time receptor endocytosis in dopamine neurons enabled by NTSR1-Venus knock-in mice.

Aliza T Ehrlich, Pierre Couvineau, Selin Schamiloglu, Stefan Wojcik, Dillon Da Fonte, Amina Mezni, Mark von Zastrow, Kevin J Bender, Michel Bouvier, Brigitte L Kieffer

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Elucidating biased signaling in class A GPCRs.Trends in pharmacological sciences · 2025
    Review
  3. Review
  4. Pain Signaling by GPCRs and RTKs.Trends in pharmacological sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Aliza T EhrlichDouglas Research Centre, Department of Psychiatry, McGill University, Montreal, QC, Canada.
Pierre CouvineauInstitut de Recherche en Immunologie et en Cancerologie (IRIC), University of Montreal, Montreal, QC, Canada.
Selin SchamilogluNeuroscience Graduate Program, University of California, San Francisco, San Francisco, CA, United States.
Stefan WojcikDouglas Research Centre, Department of Psychiatry, McGill University, Montreal, QC, Canada.
Dillon Da FonteDouglas Research Centre, Department of Psychiatry, McGill University, Montreal, QC, Canada.
Amina MezniDouglas Research Centre, Department of Psychiatry, McGill University, Montreal, QC, Canada.
Mark von ZastrowDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, United States.
Kevin J BenderDepartment of Neurology, Kavli Institute for Fundamental Neuroscience, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.
Michel BouvierInstitut de Recherche en Immunologie et en Cancerologie (IRIC), University of Montreal, Montreal, QC, Canada.
Brigitte L KiefferDouglas Research Centre, Department of Psychiatry, McGill University, Montreal, QC, Canada.
University of California, San Francisco · USDouglas Mental Health University Institute · CAUniversité de Montréal · CAInserm · FRMcGill University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dopamine (DA) neurons are primarily concentrated in substantia nigra (SN) and ventral tegmental area (VTA). A subset of these neurons expresses the neurotensin receptor NTSR1 and its putative ligand neurotensin (Nts). NTSR1, a G protein-coupled receptor (GPCR), which classically activates Gαq/calcium signaling, is a potential route for modulating DA activity. Drug development efforts have been hampered by the receptor's complex pharmacology and a lack of understanding about its endogenous location and signaling responses. Therefore, we have generated NTSR1-Venus knock-in (KI) mice to study NTSR1 receptors in their physiological context. In primary hippocampal neurons, we show that these animals express functional receptors that respond to agonists by increasing intracellular calcium release and trafficking to endosomes. Moreover, systemic agonist administration attenuates locomotion in KIs as it does in control animals. Mapping receptor protein expression at regional and cellular levels, located NTSR1-Venus on the soma and dendrites of dopaminergic SN/VTA neurons. Direct monitoring of receptor endocytosis, as a proxy for activation, enabled profiling of NTSR1 agonists in neurons, as well as acute SN/VTA containing brain slices. Taken together, NTSR1-Venus animals express traceable receptors that will improve understanding of NTSR1 and DA activities and more broadly how GPCRs act

Indexed as

brainG protein-coupled receptor (GPCR)neurotensinPD149163trafficking

Identifiers

PMID36523815
PMCPMC9745132
OpenAlexW4310208892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.